Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Contrast-enhanced MRI With Dotarem”

3 trials

Showing 3 of 3 results

Post-approval studies (Phase 4)Study completedNCT00650845
What this trial is testing

Renal Safety Evaluation After Dotarem®-Enhanced MRI

Who this might be right for
Renal Insufficiency
Guerbet 135
Post-approval studies (Phase 4)Study completedNCT03602339
What this trial is testing

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose

Who this might be right for
Magnetic Resonance Imaging
Bayer 157
Not applicableStudy completedNCT03048006
What this trial is testing

Post-marketing Surveillance Study for Evaluation of Dotarem Safety

Who this might be right for
Contrast-enhanced MRI With Dotarem
Guerbet 44,456

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation